The Relationship Between Cervical Cancer Severity and miRNA-205 Expression in Bali
Keywords:Cervical cancer, Biomarker, HPV, miRNA-205
AbstractCervical cancer is the one of leading cause of death for women worldwide. It occurs due to infection with the human papilloma virus (HPV) which attacks the cervix in the female reproductive organs. The detecting cervical cancer method is by using pap smears and liquid based cytology (LBC) and vaccinations. However, both methods are limited in detecting cervical cancer quickly and accurately. This study aims to find potential biomarkers that will be used to quickly detect the development of cervical cancer. Large-scale studies have shown that microRNA-205 (miRNA) regulation has a very important role in various types of cancer including cervical cancer. The extraction and synthesis of cDNA from 26 preparations of cervical cancer paraffin blocks were measured by quantitative real time PCR to evaluate the expression of miRNA-205 as a biomarker of cervical cancer in cervical cancer samples. Statistical results showed that there was a significant difference in the expression of miRNA-205 which was relatively higher in cervical cancer patients (p<0.05) miRNA-205. In addition, the increased expression of miRNA-205 is associated with an increase in the severity of cervical cancer. We conclude that miRNA-205 is a potential candidate for cervical cancer molecular biomarker.
Pangribowo S. Beban Kanker di Indonesia. Pus Data Dan Inf Kesehat Kementeri Kesehat RI 2019; 1–16.
Provinsi Bali DK. PROFIl KESEHATAN DINAS KESEHATAN PROVINSI BALI 2020. Kesehat Provinsi Bali 2020 2020; 3: 103–111.
Behtash N, Mehrdad N. Cervical cancer: Screening and prevention. Asian Pacific J Cancer Prev 2006; 7: 683–686.
Huang W. MicroRNAs: Biomarkers, diagnostics, and therapeutics. In: Methods in Molecular Biology. 2017, pp. 57–67.
Carter J V., Galbraith NJ, Yang D, et al. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: A systematic review and meta-analysis. Br J Cancer 2017; 116: 762–774.
Xie H, Norman I, Hjerpe A, et al. Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions. Oncol Lett 2017; 13: 3586–3598.
Aharonov R, Lebanony D, Benjamin H, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009; 27: 2030–2037.
Dorak TM (ed). Real Time PCR. United Kingdom: Taylor & Francis Group, 2006.
Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet 2019; 393: 169–182.
F F. Disease Overview Cervicitis. In: Ferry’s Clinical Advisor. ELSEVIER, https://www.clinicalkey.com/#!/topic/cervicitis?topic=cervicitis (2019).
Lusk MJ, Konecny P. Cervicitis: A review. Curr Opin Infect Dis 2008; 21: 49–55.
Bumrungthai S, Ekalaksananan T, Evans MF, et al. Up-regulation of MIR-21 is associated with cervicitis and human papillomavirus infection in cervical tissues. PLoS One 2015; 10: 1–15.
Ripoli FL, Mohr A, Hammer SC, et al. A comparison of fresh frozen vs. Formalin-fixed, paraffin-embedded specimens of canine mammary tumors via branched-DNA assay. Int J Mol Sci; 17. Epub ahead of print 2016. DOI: 10.3390/ijms17050724.
Watson JD, Baker TA, Bell SB, et al. Moleculer Biology of the Gene. Fifth. San Fransisco: Pearson Education, 2004.
Ma Q, Wan G, Wang S, et al. Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell Int 2014; 14: 1–7.
Farzanehpour M, Mozhgani SH, Jalilvand S, et al. Serum and tissue miRNAs: Potential biomarkers for the diagnosis of cervical cancer. Virol J 2019; 16: 1–9.
Lan H, Lu H, Wang X, et al. MicroRNAs as potential biomarkers in cancer: Opportunities and challenges. Biomed Res Int; 2015. Epub ahead of print 2015. DOI: 10.1155/2015/125094.
How to Cite
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).